Article

Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concern

2023-06-27

Abstract excerpt

<h4>ABSTRACT</h4> With the SARS-CoV-2 virus still circulating and evolving, there remains an outstanding question if variant-specific vaccines represent the optimal path forward, or if other strategies might be more efficacious towards providing broad protection against emerging variants. Here, we examine the efficacy of strain-specific variants of our previously reported, pan-sarbecovirus vaccine candidate, DCFH...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 07a04ec6-ff30-5f5c-a6ac-1c084ee29519
DOI: 10.1101/2023.06.27.546764

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concernDOI 10.1101/2023.06.27.546764Read

Challenges and developments in universal vaccine design against SARS-CoV-2 variantsSemantic proximity Read

SARS-CoV-2 Variants and Immune Evasion: Mapping the Future of Vaccine Design.Semantic proximity Read

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesSemantic proximity Read

Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesSemantic proximity Read

Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogensSemantic proximity Read

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsSemantic proximity Read

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protectionSemantic proximity Read

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineSemantic proximity Read

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responsesSemantic proximity Read

Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies.Semantic proximity Read

Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 VariantsSemantic proximity Read

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concernSemantic proximity Read